Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury

Journal of Neurophysiology

Volumn 105, Issue 1, 2011, Pages 410-422

  Rank, M M ^a   Murray, K C ^a   Stephens, M J ^a   D'Amico, J ^a   Gorassini, M A ^a   Bennett, D J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; CLONIDINE; METHOXAMINE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; PRAZOSIN; RX 821001; RX 921001; UK 14303; UNCLASSIFIED DRUG; WB 4010;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; IN VITRO STUDY; MUSCLE SPASM; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD INJURY; SPINAL CORD MOTONEURON; SPINAL CORD TRANSSECTION; SYNAPTIC TRANSMISSION;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; CHROMONES; CLONIDINE; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; IDAZOXAN; MODELS, ANIMAL; MOTOR NEURONS; NOREPINEPHRINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; SENSORY RECEPTOR CELLS; SPASM; SPINAL CORD INJURIES; SYNAPTIC TRANSMISSION;

EID: 78651431724     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00775.2010     Document Type: Article

References (87)

1. Adachi T, Robinson DM, Miles GB, Funk GD. Noradrenergic modulation of XII motoneuron inspiratory activity does not involve alpha2-receptor inhibition of the Ih current or presynaptic glutamate release. J Appl Physiol 98: 1297-1308, 2005.
2. Ashby P. Neurophysiology of spinal spasticity. In: Handbook of the Spinal Cord, edited by Davidoff RA. New York: Dekker, 1987, p. 120-143.
3. Baker LL, Chandler SH. Characterization of postsynaptic potentials evoked by sural nerve stimulation in hindlimb motoneurons from acute and chronic spinal cats. Brain Res 420: 340-350, 1987.
4. Baldissera F, Hultborn H, Illert M. Integration in spinal neuronal systems. In: Handbook of Physiology. The Nervous System. Motor Control, edited by Brooks VB. Bethesda: Am. Physiol. Soc., 1981, sect. 1, vol. II, p. 509-595.
5. Barbeau H, Richards CL, Bedard PJ. Action of cyproheptadine in spastic paraparetic patients. J Neurol Neurosurg Psychiatry 45: 923-926, 1982. (Pubitemid 12035161)
6. Bennett DJ, Gorassini M, Fouad K, Sanelli L, Han Y, Cheng J. Spasticity in rats with sacral spinal cord injury. J Neurotrauma 16: 69-84, 1999. (Pubitemid 29061897)
7. Bennett DJ, Li Y, Harvey PJ, Gorassini M. Evidence for plateau potentials in tail motoneurons of awake chronic spinal rats with spasticity. J Neurophysiol 86: 1972-1982, 2001.
8. Bennett DJ, Sanelli L, Cooke CL, Harvey PJ, Gorassini MA. Spastic long-lasting reflexes in the awake rat after sacral spinal cord injury. J Neurophysiol 91: 2247-2258, 2004.
9. Blakely RD, De Felice LJ, Hartzell HC. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196: 263-281, 1994.
10. Boulenguez P, Liabeuf S, Bos R, Bras H, Jean-Xavier C, Brocard C, Stil A, Darbon P, Cattaert D, Delpire E, Marsala M, Vinay L. Downregulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat Med 16: 302-307, 2010.
11. Boyajian CL, Leslie FM. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain. J Pharmacol Exp Ther 241: 1092-1098, 1987.
12. Button DC, Kalmar JM, Gardiner K, Marqueste T, Zhong H, Roy RR, Edgerton VR, Gardiner PF. Does elimination of afferent input modify the changes in rat motoneurone properties that occur following chronic spinal cord transection? J Physiol 586: 529-544, 2008.
13. Chau C, Barbeau H, Rossignol S. Effects of intrathecal alpha1- and alpha2-noradrenergic agonists and norepinephrine on locomotion in chronic spinal cats. J Neurophysiol 79: 2941-2963, 1998. (Pubitemid 28317025)
14. Clarke RW, Eves S, Harris J, Peachey JE, Stuart E. Interactions between cutaneous afferent inputs to a withdrawal reflex in the decerebrated rabbit and their control by descending and segmental systems. Neuroscience 112: 555-571, 2002.
15. 1A-selective adrenoreceptor agonists for the treatment of urinary incontinence; US Patent, edited by Office USPaT. United States of America: Synaptic Pharmaceutical, 1997, p. 23.
16. Crone C, Johnsen LL, Biering-Sorensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 126: 495-507, 2003.
17. Doxey JC, Roach AG, Smith CF. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 78: 489-505, 1983.
18. Elliott P, Wallis DI. Serotonin and L-norepinephrine as mediators of altered excitability in neonatal rat motoneurons studied in vitro. Neuroscience 47: 533-544, 1992.
19. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135, 1997.
20. Fung SJ, Manzoni D, Chan JY, Pompeiano O, Barnes CD. Locus coeruleus control of spinal motor output. Prog Brain Res 88: 395-409, 1991.
21. Funk GD, Smith JC, Feldman JL. Development of thyrotropin-releasing hormone and norepinephrine potentiation of inspiratory-related hypoglossal motoneuron discharge in neonatal and juvenile mice in vitro. J Neurophysiol 72: 2538-2541, 1994.
22. Gabbay H, Lev-Tov A. Alpha-1 adrenoceptor agonists generate a "fast" NMDA receptor-independent motor rhythm in the neonatal rat spinal cord. J Neurophysiol 92: 997-1010, 2004.
23. Gimenez y Ribotta M, Privat A. Biological interventions for spinal cord injury. Curr Opin Neurol 11: 647-654, 1998.
24. Giroux N, Rossignol S, Reader TA. Autoradiographic study of alpha1- and alpha2-noradrenergic and serotonin1A receptors in the spinal cord of normal and chronically transected cats. J Comp Neurol 406: 402-414, 1999. (Pubitemid 29136413)
25. Gorassini MA, Knash ME, Harvey PJ, Bennett DJ, Yang JF. Role of motoneurons in the generation of muscle spasms after spinal cord injury. Brain 127: 2247-2258, 2004.
26. Hammar I, Jankowska E. Modulatory effects of alpha1-, alpha2-, and beta -receptor agonists on feline spinal interneurons with monosynaptic input from group I muscle afferents. J Neurosci 23: 332-338, 2003.
27. Harvey PJ, Li X, Li Y, Bennett DJ. 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 96: 1158-1170, 2006a.
28. Harvey PJ, Li X, Li Y, Bennett DJ. Endogenous monoamine receptor activation is essential for enabling persistent sodium currents and repetitive firing in rat spinal motoneurons. J Neurophysiol 96: 1171-1186, 2006b. (Pubitemid 44371512)
29. Harvey PJ, Li Y, Li X, Bennett DJ. Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats. J Neurophysiol 96: 1141-1157, 2006c.
30. Hochman S, Garraway SM, Machacek DW, Shay BL. 5-HT receptors and the neuromodulatory control of spinal cord function. In: Neurobiology of the Spinal Cord, edited by Cope T. Washington, DC: CRC, 2003, p. 47-87.
31. Hounsgaard J, Hultborn H, Jespersen B, Kiehn O. Bistability of alphamotoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5-hydroxytryptophan. J Physiol 405: 345-367, 1988.
32. Hultborn H, Brownstone RB, Toth TI, Gossard JP. Key mechanisms for setting the input-output gain across the motoneuron pool. Prog Brain Res 143: 77-95, 2004. (Pubitemid 37442983)
33. Jacobs BL, Martin-Cora FJ, Fornal CA. Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev 40: 45-52, 2002.
34. Jankowska E, Hammar I. Spinal interneurones; how can studies in animals contribute to the understanding of spinal interneuronal systems in man? Brain Res Brain Res Rev 40: 19-28, 2002. (Pubitemid 36183155)
35. Jankowska E, Hammar I, Chojnicka B, Heden CH. Effects of monoamines on interneurons in four spinal reflex pathways from group I and/or group II muscle afferents. Eur J Neurosci 12: 701-714, 2000.
36. Jankowska E, Riddell JS, Skoog B, Noga BR. Gating of transmission to motoneurones by stimuli applied in the locus coeruleus and raphe nuclei of the cat. J Physiol 461: 705-722, 1993. (Pubitemid 23104414)
37. Jasper JR, Lesnick JD, Chang LK, Yamanishi SS, Chang TK, Hsu SA, Daunt DA, Bonhaus DW, Eglen RM. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol 55: 1035-1043, 1998.
38. Jordan LM, Liu J, Hedlund PB, Akay T, Pearson KG. Descending command systems for the initiation of locomotion in mammals. Brain Res Rev 57: 183-191, 2008. (Pubitemid 350213101)
39. Knepper SM, Buckner SA, Brune ME, DeBernardis JF, Meyer MD, Hancock AA. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype. J Pharmacol Exp Ther 274: 97-103, 1995.
40. Kuhn RA, Macht MB. Some manifestations of reflex activity in spinal man with particular reference to the occurrence of extensor spasm. Bull Johns Hopkins Hosp 84: 43-75, 1949.
41. Lapointe NP, Ung RV, Rouleau P, Guertin PA. Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice. J Pharmacol Exp Ther 325: 994-1006, 2008.
42. Lee RH, Heckman CJ. Enhancement of bistability in spinal motoneurons in vivo by the noradrenergic alpha1 agonist methoxamine. J Neurophysiol 81: 2164-2174, 1999.
43. Lee RH, Heckman CJ. Adjustable amplification of synaptic input in the dendrites of spinal motoneurons in vivo. J Neurosci 20: 6734-6740, 2000.
44. Li X, Bennett DJ. Apamin-sensitive calcium-activated potassium currents (SK) are activated by persistent calcium currents in rat motoneurons. J Neurophysiol 97: 3314-3330, 2007.
45. Li X, Murray K, Harvey PJ, Ballou EW, Bennett DJ. Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 97: 1236-1246, 2007. (Pubitemid 46239501)
46. Li Y, Bennett DJ. Persistent sodium and calcium currents cause plateau potentials in motoneurons of chronic spinal rats. J Neurophysiol 90: 857-869, 2003. (Pubitemid 37092571)
47. Li Y, Gorassini MA, Bennett DJ. Role of persistent sodium and calcium currents in motoneuron firing and spasticity in chronic spinal rats. J Neurophysiol 91: 767-783, 2004a. (Pubitemid 38168850)
48. Li Y, Harvey PJ, Li X, Bennett DJ. Spastic long-lasting reflexes of the chronic spinal rat studied in vitro. J Neurophysiol 91: 2236-2246, 2004b.
49. Lundberg A. Inhibitory control from the brainstem of transmission from primary afferents to motoneurons, primary afferent terminals and ascending pathways. In: Brain Stem Control of Spinal Mechanisms, edited by Sjolund , Bjorklund A. New York: Elsevier, 1982, p. 179-224.
50. Magnusson T. Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryptamine in the rat spinal cord. Naunyn Schmiedebergs Arch Pharmacol 278: 13-22, 1973.
51. Maynard FM, Karunas RS, Waring WP, 3rd. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 71: 566-569, 1990.
52. McNicholas LF, Martin WR, Sloan JW, Nozaki M. Innervation of the spinal cord by sympathetic fibers. Exp Neurol 69: 383-394, 1980. (Pubitemid 10034853)
53. Mehrotra S, Gupta S, Centurion D, Villalon CM, Saxena PR, Vanden-Brink AM. A61603-induced contractions of the porcine meningeal artery are mediated by alpha1- and alpha2-adrenoceptors. Basic Clin Pharmacol Toxicol 100: 279-285, 2007.
54. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 32: 197-200, 1994.
55. Millan MJ. Descending control of pain. Prog Neurobiol 66: 355-474, 2002.
56. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther 295: 1192-1205, 2000.
57. Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol 46: 929-936, 1994. (Pubitemid 24364107)
58. Murray KC, Nakae A, Stephens MJ, Rank M, D'Amico J, Harvey PJ, Li X, Harris RL, Ballou EW, Anelli R, Heckman CJ, Mashimo T, Vavrek R, Sanelli L, Gorassini MA, Bennett DJ, Fouad K. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT(2C) receptors. Nat Med 16: 694-700, 2010.
59. Murray K, Stephens MJ, Ballou EW, Anelli R, Heckman CJ, Bennett DJ. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J Neurophysiol In press.
60. Nance PW. A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients. J Am Paraplegia Soc 17: 150-156, 1994.
61. Noguera MA, Ivorra MD, D'Ocon P. Functional evidence of inverse agonism in vascular smooth muscle. Br J Pharmacol 119: 158-164, 1996. (Pubitemid 26294535)
62. Norton JA, Bennett DJ, Knash ME, Murray KC, Gorassini MA. Changes in sensory-evoked synaptic activation of motoneurons after spinal cord injury in man. Brain 131: 1478-1491, 2008.
63. Nozaki M, Bell JA, Martin WR. Noradrenergic action of amphetamine following degeneration of descending monoaminergic fibers in the spinal cord. Psychopharmacology 67: 25-29, 1980. (Pubitemid 10173716)
64. Parkis MA, Berger AJ. Clonidine reduces hyperpolarization-activated inward current (Ih) in rat hypoglossal motoneurons. Brain Res 769: 108-118, 1997.
65. Pauwels PJ, Tardif S, Wurch T, Colpaert FC. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism. J Pharmacol Exp Ther 292: 654-663, 2000.
66. Perrier JF, Delgado-Lezama R. Synaptic release of serotonin induced by stimulation of the raphe nucleus promotes plateau potentials in spinal motoneurons of the adult turtle. J Neurosci 25: 7993-7999, 2005.
67. Popovich PG, Horner PJ, Mullin BB, Stokes BT. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol 142: 258-275, 1996.
68. Rank MM, Li X, Bennett DJ, Gorassini MA. Role of endogenous release of norepinephrine in muscle spasms after chronic spinal cord injury. J Neurophysiol 97: 3166-3180, 2007.
69. Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL. Synaptic control of motoneuronal excitability. Physiol Rev 80: 767-852, 2000.
70. Rossier O, Abuin L, Fanelli F, Leonardi A, Cotecchia S. Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes. Mol Pharmacol 56: 858-866, 1999.
71. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41, 2001.
72. Roudet C, Mouchet P, Feuerstein C, Savasta M. Normal distribution of alpha 2-adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: a quantitative autoradiographic study. J Neurosci Res 39: 319-329, 1994. (Pubitemid 24331301)
73. Roudet C, Savasta M, Feuerstein C. Normal distribution of alpha-1-adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: a quantitative autoradiographic study. J Neurosci Res 34: 44-53, 1993. (Pubitemid 23014253)
74. Sakitama K. Intrathecal noradrenaline facilitates and inhibits the flexor reflex mediated by group II afferent fibers via alpha 1- and alpha 2-receptors, respectively. Jpn J Pharmacol 62: 131-136, 1993. (Pubitemid 23218231)
75. Sanders JD, Szot P, Weinshenker D, Happe HK, Bylund DB, Murrin LC. Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice. Brain Res 1109: 45-53, 2006.
76. Schmidt BJ, Jordan LM. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res Bull 53: 689-710, 2000.
77. Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP, Campbell S, Fidock MD, Furness LM, Parry-Smith DJ, Peters B, Bailey DS. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther 272: 134-142, 1995.
78. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366: 381-416, 2002.
79. Shefchyk SJ, Jordan LM. Excitatory and inhibitory postsynaptic potentials in alpha-motoneurons produced during fictive locomotion by stimulation of the mesencephalic locomotor region. J Neurophysiol 53: 1345-1355, 1985.
80. Shibata K, Foglar R, Horie K, Obika K, Sakamoto A, Ogawa S, Tsujimoto G. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 48: 250-258, 1995.
81. Takeoka A, Kubasak MD, Zhong H, Kaplan J, Roy RR, Phelps PE. Noradrenergic innervation of the rat spinal cord caudal to a complete spinal cord transection: effects of olfactory ensheathing glia. Exp Neurol 222: 59-69, 2010.
82. Tremblay LE, Bedard PJ. Action of 5-hydroxytryptamine, substance P, thyrotropin releasing hormone and clonidine on spinal neuron excitability. J Spinal Cord Med 18: 42-46, 1995.
83. U'Prichard DC, Greenberg DA, Snyder SH. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 13: 454-473, 1977.
84. Udina E, D'Amico J, Bergquist AJ, Gorassini MA. Amphetamine increases persistent inward currents in human motoneurons estimated from paired motor unit activity. J Neurophysiol 103: 1295-1303, 2010.
85. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 101: 107-117, 2006.
86. Yoshio R, Taniguchi T, Itoh H, Muramatsu I. Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes. Jpn J Pharmacol 86: 189-195, 2001.
87. Young RR. Spasticity: a review. Neurology 44: S12-20, 1994.